Primary Care Clinics in Glen Alpine, NC Accepting Medicare
1 Primary Care Clinics found. Showing 1 - 1
 Table Rock Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 Linville Street, Glen Alpine, NC 28628 Phone: 828-584-2481 Fax: 828-584-8371 |
News Archive
Canadian researchers uncover new molecular mechanism to stop proliferation of cancer cells
Canadian researchers have discovered a new and direct molecular mechanism to stop cancer cells from proliferating. In the prestigious journal Nature Cell Biology, scientists from Université de Montréal show that a disruption of a fine balance in the composition of ribosomes (huge molecules that translate the genetic code into proteins) results in a shutdown of cancer cell proliferation, triggering a process called senescence.
Neuroscientists watch memories form in real time
Our ability to form long-term memories depends on cells in the brain making strong connections with each other. Yet while it's not well understood how those connections are made, lost or changed, the process is known to involve the movement of the AMPA receptor protein to and from those neuronal connections.
Inovio Biomedical introduces new CELLECTRA-SP series of hand-held, cordless electroporation devices
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, has unveiled its new CELLECTRA®-SP series of hand-held, cordless electroporation devices at the DNA Vaccines 2010 conference being held in New Orleans, LA.
Pharmacogenomics Centre deploys the Isilon IQ to accelerate its next-generation genetic sequencing operations
Isilon® Systems (Nasdaq: ISLN), the proven leader in scale-out NAS, today announced that Pharmacogenomics Centre, a partnership between Genome Quebec and the Montreal Heart Institute focused on enhancing new and existing drug development research programs through the inclusion of genetic information, has deployed Isilon IQ to accelerate its next-generation genetic sequencing operations.
Positive results from Jennerex JX-594 proof-of-concept trial on metastatic melanoma
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, today announced that positive results from a proof-of-concept clinical trial using JX-594 to treat patients with metastatic melanoma were published in the peer-reviewed journal Molecular Therapy.
› Verified 1 days ago